Figure 2.
CYP2D6 genotype-predicted phenotype frequencies in the nine virtual populations (n = 10,000 patients) representing the biogeographical groups defined in [28]. gNM, gIM, and gPM: genotype-predicted normal, intermediate, and poor metabolizers, respectively.